ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Also C-Change new name for National Dialogue on Cancer.

January 16, 2004

Cancer Meetings Listed For Next Three Months

September 20, 1996

Waksals Keep ImClone Jobs, BMS Pumps $200M Into C225

March 8, 2002

Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy.

June 30, 2000

55 NCI Grantees Win Shannon Awards, NCI gets $5.2 Mil.

October 4, 1991

In Brief: OMB Still Dragging Its Feet On New Construction Money Schmidt Pressure Gets 70 Slots For NCI

May 23, 1975